News
- All
- Awards
- Events
- News
- Press Releases
Quality management system certification ISO 13485:2016 renewed
February 28, 2024. [NEWS] Company We are proud to announce that we have received the renewal of our …
Translating the regulatory landscape of medical devices to create fit-for-purpose artificial intelligence (AI) cytometry solutions
February 23, 2024. [SCIENTIFIC PUBLICATION] Company ; METAflow We are pleased to highlight our col…
Raising awareness on rare diseases like Glut1DS at the annual meeting of EPNS 2023
June 20, 2023 [EVENTS] Company ; METAglut1™ We had the honor of attending the 15th Annual Meeting …
Coverage recommandation for our innovative IVD test METAglut™ by French National Authority for Health (HAS)
May 3, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that our innovative in v…
Evaluation of our innovative IVD test METAglut™ published by French National Authority for Health (HAS)
April 27, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that the Haute Autorité …
Prospective Multicenter Validation of a Simple Blood Test for the Diagnosis of Glut1 Deficiency Syndrome
April 19, 2023. [SCIENTIFIC PUBLICATION] Company ; METAglut1™ We are pleased to highlight our co…
EIC Accelerator Funding awarded to drive innovation and next-level growth
November 19, 2022. [AWARDS] Company We are thrilled to announce that we have been awarded funding …
Introducing METAflow our innovative AI cytometry data analysis platform at ESCCA 2022
September 21-24, 2022. [EVENTS] Company ; METAflow We were proud to showcase METAflow at our booth…
Testimonial from Dr. Domitille Gras on our innovative IVD test METAglut™ during World Health Day 2022
May 3, 2023. [NEWS] Company ; METAglut1™ We are proud to share insights from Dr. Domitille G…
Revealing key findings from our METAglut1™ validation study at the meeting of SENP 2022
February 17, 2022 [EVENTS] Company ; METAglut1™ We were excited to participate in the 48th meeting…
Poster presentation on METAglut1™ our innovative IVD blood test at the meeting of SFNP 2022
February 2-4, 2022. [EVENTS] Company ; METAglut1™ We are thrilled to share our experience at the…
Strategic partnership with Sebia to develop innovative in vitro diagnostics
September 16, 2021. [NEWS] Company Lisses et Paris, 16 septembre 2021. Sebia, leader mo…
Latest Findings on our Validation Study Announced at the European GLUT1D Conference
June 19, 2021. [NEWS] Company ; METAglut1™ We were thrilled to attend the 3rd European Confe…
Updates at the European Conference on Glut1 Deficiency 2021
June 11, 2021. [EVENTS] Company ; METAglut1™ We were thrilled to eventually attend the 3rd E…
Quality management system certification ISO 13485:2016 obtained
March 22, 2021. [NEWS] Company We are proud to announce that we have obtained our Quality Mana…
New results on METAglut1™ validation study presented at the meeting of SFNP 2020
January 15-17, 2020. [EVENTS] Company ; METAglut1™ We are thrilled that our intermediate results …
Early patient access to health technologies: Is innovation needed for early management?
December 16, 2019. [SCIENTIFIC PUBLICATION] Company We are pleased to highlight our collaborativ…
Attending the 2019 Summit of the Glut1 Deficiency Foundation to talk about METAglut1™ our innovative IVD blood test
July 11-12, 2019. [EVENTS] Company ; METAglut1™ We are thrilled to participate in the 2019 annua…
Proud Laureate of the PhD Paris Region Funding Initiative
June 21, 2019. [AWARDS] Company Alongside our partners INRIA and Université Paris-Saclay, we are …
Usefulness of diagnostic tools in a GLUT1 deficiency syndrome patient with 2 inherited mutations
June 10, 2019. [SCIENTIFIC PUBLICATION] Company ; METAglut1™ We are pleased to highlight our col…
Oral presentation on METAglut1™ our innovative IVD blood test at the meeting of SENP 2019
March 22, 2019 [EVENTS] Company ; METAglut1™ We had the honor of presenting at the 47th Annual Mee…
€1M Grant from Bpifrance’s Innovation Prize
February 20, 2019. [AWARDS] Company As the prizewinner of the “Concours Innovation” organized by…
Poster presentation on METAglut1™ our innovative IVD blood test at the meeting of SFNP 2019
January 16-18, 2019 [EVENTS] Company ; METAglut1™ We were thrilled to share the preliminary result…
Booth at the European Conference on Glut1 Deficiency 2018
June 22-24, 2018. [EVENTS] Company ; METAglut1™ We are thrilled to have our first booth at the 2…
€3.2M Grant awarded: major boost for the launch of our validation study
June 11, 2018. [AWARDS] Company ; METAglut1™ As a company developing diagnostic tests to detect ab…
Booth to discuss latest results on METAglut1™ at the meeting of SENP 2018
April 27, 2018 [EVENTS] Company ; METAglut1™ We had the honor of exhibiting at the 46th Annual Mee…
Attending the summit of the Glut1 Deficiency Foundation 2017 to talk about METAglut1™ our innovative IVD blood test
July 13-14, 2017. [EVENTS] Company ; METAglut1™ We are thrilled to participate in the 2017 annua…
A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome
July, 2017. [SCIENTIFIC PUBLICATION] Company ; METAglut1™ We are pleased to highlight our collab…
Results of our first study with AP-HP and the ICM on our innovative IVD test METAglut™ published in Annals of Neurology
June 12, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that the results of our fi…
European regulatory approval successfully obtained for METAglut1™ our innovative IVD test for Glut1DS
Launch of our first innovative IVD test METAglut1™ to aid the diagnosis of Glut1DS developed with our partner CERBA HealthCare
February 2, 2017. [NEWS] Company ; METAglut1™ We are thrilled to announce a significant mileston…
Company milestones shared at the Actionaria Event 2016
November 18, 2016. [EVENTS] Company Vincent Petit, CEO, and Romain Kaspereit, CFO of METAFORA Bi…
Alliance with Cerba HealthCare to advance metabolomics and drive diagnostic innovations
November 7, 2016. [NEWS] Company Paris, November 7, 2016. The Cerba HealthCare Group and MET…
Inauguration meeting with our international scientific board of leading experts to enhance GLUT1DS diagnosis
October 10, 2021. [NEWS] Company ; METAglut1™ In line with our development strategy, we conv…
Attending the first European Conference on Glut1 Deficiency
October 7-8, 2016. [EVENTS] Company ; METAglut1™ We are thrilled to attend the very 1st European C…
Exclusive Interview with BFM Business Radio: our participation in the BigBooster Program
April 16, 2016. [NEWS] Company In this interview, lead by BFM Business Radio, METAFORA’s CEO V…
Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions
April 12, 2016. [SCIENTIFIC PUBLICATION] Company We are thrilled to announce new findings from N…
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
April 12, 2016. [SCIENTIFIC PUBLICATION] Company We are excited to share a scientific publicatio…
Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice
February 29, 2016 [SCIENTIFIC PUBLICATION] Company ; METAglut1™ We are excited to showcase new fin…
Selected for the BigBooster Acceleration Program
February 10, 2016. [NEWS] Company METAFORA is one of the top 20 french start-up selected by the BigB…
Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem Cells
August 6, 2015. [SCIENTIFIC PUBLICATION] Company We are pleased to highlight our collaborative res…
Company Strategy Vision Presented at the First International Biotechnology Meeting
July 1, 2015. [EVENTS] Company Vincent Petit, CEO of METAFORA Biosystems, took the stage at the …
